Pierluigi Paggiaro

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 4 papers. Top paper: “Effect of Dupilumab on Blood Eosinophil Counts in Patients With Asthma, Chronic Rhinosinusitis With Nasal Polyps, Atopic Dermatitis, or Eosinophilic Esophagitis”.

Effect of Dupilumab on Blood Eosinophil Counts in Patients With Asthma, Chronic Rhinosinusitis With Nasal Polyps, Atopic Dermatitis, or Eosinophilic Esophagitis

The Journal of Allergy and Clinical Immunology In Practice(2022)10.1016/j.jaip.2022.05.019

N/A

6.6DataRank · unranked

233 citations

Amy D. Klion, Pierluigi Paggiaro, Parameswaran Nair, D. Staumont‐Sallé, Amr Radwan +12 more

Impact of baseline patient characteristics on dupilumab efficacy in type 2 asthma

European Respiratory Journal(2021)10.1183/13993003.04605-2020

N/A

1.4DataRank · unranked

29 citations

Pierluigi Paggiaro, Xavier Muñoz, Thomas B. Casale, Mario Castro, Giorgio Walter Canonica +6 more

The role of small airway dysfunction in asthma control and exacerbations: a longitudinal, observational analysis using data from the ATLANTIS study

The Lancet Respiratory Medicine(2022)10.1016/s2213-2600(21)00536-1

N/A

0DataRank · unranked

137 citations

Matthew Richardson, Brian Hallmark, Dean Billheimer, Maarten van den Berge, Leonardo M. Fabbri +31 more

Predictors and associations of the persistent airflow limitation phenotype in asthma: a post-hoc analysis of the ATLANTIS study

The Lancet Respiratory Medicine(2022)10.1016/s2213-2600(22)00185-0

N/A

0DataRank · unranked

70 citations

E. Vanden Berghe, Monica Kraft, Judith M. Vonk, Martijn C. Nawijn, Salman Siddiqui +95 more